What is the equity of PeptiDream this year?
PeptiDream has equity of 40.35 B JPY this year.
PeptiDream Equity 2024
PeptiDream Equity
40.35 B JPY
Ticker
4587.T
ISIN
JP3836750004
WKN
A1W0KK
In 2024, PeptiDream's equity was 40.35 B JPY, a 25.93% increase from the 32.04 B JPY equity in the previous year.
PeptiDream Aktienanalyse
What does PeptiDream do?
PeptiDream Inc is a Japanese biotech company specializing in novel therapeutics and drugs. The company was founded in 2006 by Professor Hiroaki Suga, who established the field of peptide synthesis at the University of Tokyo. Peptides are short chains of amino acids used in pharmaceutical development and diagnosis. PeptiDream uses a patented technology to generate billions of different peptides, which can then be systematically tested for functionality and applicability. The company also utilizes artificial intelligence and machine learning to specifically find compounds that can potentially treat cancer or neurodegenerative diseases. PeptiDream has four diverse business areas focusing on different applications. The first area is the identification of new drugs, where the company collaborates with several pharmaceutical and biotech firms to develop new compounds. The second area focuses on the development of peptide-based diagnostics. An example of this is the PeelAVERT technology, which identifies cancer-causing proteins through a "peeling process" of skin samples. This allows for personalized cancer treatment and improves success rates. The third area involves the development of agrochemicals. PeptiDream aims to replace chemical pesticides with biodegradable peptide-based compounds that have no negative impact on the environment. The fourth area aims to enhance quality of life through the use of peptides. The company focuses on compounds that can strengthen the immune system or slow down the aging process. PeptiDream has made several groundbreaking discoveries, including the PD-1 inhibitor technology for cancer treatment. This method uses peptides to activate the body's immune system and kill cancer cells. PD-1 inhibitors have shown promising results in clinical studies for lung cancer, kidney cancer, and other tumor types. PeptiDream has also developed a technology called "Peptide Discovery Platform System 2.0," which allows for the rapid generation and analysis of billions of diverse peptides. This method has been patented and enables PeptiDream to quickly focus on the development of new compounds. PeptiDream is a global leader in the development of peptide therapeutics and diagnostics. The company has earned an excellent reputation and collaborates closely with various research institutions, pharmaceutical companies, and biotech firms. PeptiDream also invests in training the next generation of scientists and strives to provide the industry and society with new compounds. PeptiDream ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing PeptiDream's Equity
PeptiDream's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding PeptiDream's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating PeptiDream's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
PeptiDream's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in PeptiDream’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about PeptiDream stock
What was the equity of PeptiDream compared to the previous year?
The equity of PeptiDream has increased/decreased by 25.93% increased compared to the previous year.
What impact does a high equity have on investors of PeptiDream?
A high equity is advantageous for investors of PeptiDream as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of PeptiDream?
A low equity can be a risk for investors of PeptiDream, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of PeptiDream affect the company?
An increase in equity of PeptiDream can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of PeptiDream affect the company?
A reduction in equity of PeptiDream can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of PeptiDream?
Some factors that can affect the equity of PeptiDream include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of PeptiDream so important for investors?
The equity of PeptiDream is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can PeptiDream take to change the equity?
To change equity, PeptiDream can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does PeptiDream pay?
Over the past 12 months, PeptiDream paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PeptiDream is expected to pay a dividend of 0 JPY.
What is the dividend yield of PeptiDream?
The current dividend yield of PeptiDream is .
When does PeptiDream pay dividends?
PeptiDream pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of PeptiDream?
PeptiDream paid dividends every year for the past 0 years.
What is the dividend of PeptiDream?
For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.
In which sector is PeptiDream located?
PeptiDream is assigned to the 'Health' sector.
Wann musste ich die Aktien von PeptiDream kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PeptiDream from 10/1/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.
When did PeptiDream pay the last dividend?
The last dividend was paid out on 10/1/2024.
What was the dividend of PeptiDream in the year 2023?
In the year 2023, PeptiDream distributed 0 JPY as dividends.
In which currency does PeptiDream pay out the dividend?
The dividends of PeptiDream are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PeptiDream
Our stock analysis for PeptiDream Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PeptiDream Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
